Valeant shares pop on reports company has found its new CEO

Shares of Valeant Pharmaceuticals shot up Friday morning following reports that Valeant is close to luring the head of over-the-counter drugmaker Perrigo to become its next chief executive officer.

The Wall Street Journal reported Thursday that Valeant is finalizing a contract with Perrigo chairman and CEO
Joseph C. Papa and could announced the hire as early as next week.

Perrigo said Friday it is aware of the report but added that it would not comment on "speculation or
market rumour."

In the wake of the report, Valeant's stock was up more than seven per cent at $45.50 in morning trading on the TSX. The stock got as high as $46.18 earlier in the session.

Valeant, which is under intense scrutiny in the U.S. for its strategy of buying small drugmakers, then raising prices sharply on older, off-patent drugs, said back in March that it would replace CEO Michael Pearson after its share price tumbled. The hit a high in August 2015 above $346, but has since retreated as pressure mounted on the company.

Let's block ads! (Why?)

Share on Google Plus

About Quang

My blog is the place to update the latest information on sports, science and technology ... If you found this article good, useful please the share for others to see, even if you want to design a ecommerce website or web edit or set a special plugin functionality, please contact us now (Information in the footer)